Fundraising FoxSCP Vitalife Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Regentisregentis.co.ilJun 2026
Regentis Biomaterials develops regenerative medicine products for tissue repair, focused on orthopedic cartilage and bone treatments through its Gelrin degradable hydrogel platform.
BiotechHealthtechMedical DevicesHerzliya, IL
Galit Reske(Executive Officer)Arie Gordashnikov(Executive Officer)Ori Gon(Executive Officer)in
BoardEhud Geller(Executive Officer, Director)Susan Alpert(Director)
Board seatJeff Dykan· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.